Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Study finds two substances capable of inhibiting proliferation of glioblastoma cells

Glioblastoma is a malignant tumor of the central nervous system (brain or spinal cord) and one of the deadliest types of cancer.

7 Mar 2023

Therapeutic ketosis for mild cognitive impairment, Alzheimer's and Parkinson's

A new study in Frontiers in Neurology aimed to review the available studies which support the clinical utility of ketogenic interventions in PD, MCI, and AD.

5 Mar 2023

PARK2 duplication or microdeletion and neurological diseases

In a recent study published in the Genes journal, researchers assessed the impact of PARK2 duplication or microdeletion on neurological diseases such as Parkinson's.

28 Feb 2023

Three intestinal bacteria associated with dementia with Lewy bodies discovered

Dementia with Lewy bodies (DLB), one of the most common forms of dementia, has no cure. Previous studies suggested that gut bacteria, the microorganisms that live in the human digestive tract, play a role in Parkinson's disease, another neurodegenerative disorder, but the bacteria involved in DLB had not been identified.

28 Feb 2023

Tiny worm enables scientists to explore the theory that Parkinson's disease starts in the gut

A tiny worm called the C. elegans is enabling scientists to explore the emerging theory that Parkinson's disease starts in the gut.

28 Feb 2023

New discovery could shift the focus of Parkinson’s disease treatment

Researchers from the University of Queensland have identified that a gene associated with an increased risk of Parkinson's Disease also contributes to a build-up of cell debris in the brain.

24 Feb 2023

Young people with good sleep habits less likely to die early

Getting good sleep can play a role in supporting your heart and overall health - and maybe even how long you live - according to new research being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

23 Feb 2023

Minimally invasive focused ultrasound treatment improves symptoms in patients with Parkinson's disease

Patients with Parkinson's disease achieved a significant improvement in their tremors, mobility, and other physical symptoms after having a minimally invasive procedure involving focused ultrasound, according to a new study today published in the New England Journal of Medicine.

23 Feb 2023

Study reports that depleting gut bacteria in mice with genetic risk for AD reduces neuropathology in a sex-dependent manner

Researchers highlight recent research investigating whether gut microbiota regulates tau pathology and tau-mediated neurodegeneration in an ApoE isoform–dependent manner.

21 Feb 2023

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

Researchers presented eight hallmarks of neurodegenerative diseases (NDDs), their in vivo biomarkers, and interactions to help categorize NDDs and specify patients within a specific NDD.

21 Feb 2023

FAU collaborates with Delray Medical Center, Insightec to fight against Alzheimer's disease

Delray Medical Center is the first hospital in Florida to treat an Alzheimer's disease patient using non-invasive focused ultrasound technology as part of a groundbreaking study being conducted in collaboration with Florida Atlantic University's Institute for Human Health and Disease Intervention (I-Health).

17 Feb 2023

Scientists discover how a "poisoned" form of protein could spur cancer formation

Scientists at Scripps Research, with collaborators in Japan, have discovered how a "poisoned" form of a protein could set off a cascade of events that encourage the growth of some cancers.

17 Feb 2023

Elevated level of α-synuclein aggregates in stool samples can indicate early form of Parkinson’s

The so-called isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance.

16 Feb 2023

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the capability of two small molecules of disintegrating alpha-synuclein fibrils.

13 Feb 2023

PTSD patients may repeatedly experience emotionally charged dreams during REM sleep

During periods of rapid eye movement (REM) sleep, brain activity often resembles that of awake behavior. At times, the brain can actually be more active during REM sleep than when you're awake.

9 Feb 2023

Study finds distinct differences in how the brain releases dopamine in patients with alcohol use disorder

Dopamine is a neurotransmitter that's made in the brain and acts as a chemical messenger, communicating between nerve cells in the brain and the rest of the body.

7 Feb 2023

ERES IV acquires a majority stake in Oncodesign Services

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, representing 61.58% of its share capital, from its main shareholders, including Mr. Philippe Genne, Founder of Oncodesign Services, as well as certain key shareholders and several managers and minority shareholders, following the entry into exclusive negotiations on June 30, 2022.

From Oncodesign Services 3 Feb 2023

UC Davis launches new institute to advance basic knowledge of psychedelics and neurotherapeutics

The University of California, Davis has launched the Institute for Psychedelics and Neurotherapeutics to advance basic knowledge about the mechanisms of psychedelics and translate it into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer's disease and Parkinson's disease, among others.

2 Feb 2023

Data-driven algorithm predicts deep brain stimulation parameters for Parkinson’s treatment

Researchers assesses the effects of stimulation parameters suggested by a recently published data-driven algorithm (StimFit) based on neuroimaging data.

31 Jan 2023

A neural interface to detect and alleviate symptoms of neurological disorders

EPFL researchers have combined low-power chip design, machine learning algorithms, and soft implantable electrodes to produce a neural interface that can identify and suppress symptoms of various neurological disorders.

30 Jan 2023

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Study finds two substances capable of inhibiting proliferation of glioblastoma cells

Therapeutic ketosis for mild cognitive impairment, Alzheimer's and Parkinson's

PARK2 duplication or microdeletion and neurological diseases

Three intestinal bacteria associated with dementia with Lewy bodies discovered

Tiny worm enables scientists to explore the theory that Parkinson's disease starts in the gut

New discovery could shift the focus of Parkinson’s disease treatment

Young people with good sleep habits less likely to die early

Minimally invasive focused ultrasound treatment improves symptoms in patients with Parkinson's disease

Study reports that depleting gut bacteria in mice with genetic risk for AD reduces neuropathology in a sex-dependent manner

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

FAU collaborates with Delray Medical Center, Insightec to fight against Alzheimer's disease

Scientists discover how a "poisoned" form of protein could spur cancer formation

Elevated level of α-synuclein aggregates in stool samples can indicate early form of Parkinson’s

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

PTSD patients may repeatedly experience emotionally charged dreams during REM sleep

Study finds distinct differences in how the brain releases dopamine in patients with alcohol use disorder

ERES IV acquires a majority stake in Oncodesign Services

UC Davis launches new institute to advance basic knowledge of psychedelics and neurotherapeutics

Data-driven algorithm predicts deep brain stimulation parameters for Parkinson’s treatment

A neural interface to detect and alleviate symptoms of neurological disorders

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in